Los Angeles, CA, United States of America

Zhen Gu

This inventor holds 30 USPTO granted patents and 27 published patent applications and 14 EPO patents, primarily in Microneedle Drug Delivery. Top assignees: North Carolina State University, University of California, Columbia University. Active years: 2016-2026.

USPTO Granted Patents = 30 (Patent Applications = 27)

% Patents Active = 90.0

EPO Patents = 14 (Patent Applications = 26)

Average Co-Inventor Count = 2.3

ph-index = 3

Forward Citations = 42(Granted Patents)

Location History:

Apex, NC (US) (2018 - 2023)
Los Angeles, CA (US) (2016 - 2024)
Raleigh, NC (US) (2021 - 2024)

Company Filing History:

27 out of 1,489

North Carolina State University

patents

3 out of 16,008

University of California

where one patent can have more than one assignee

Years Active: 2016-2026

Loading Chart...

Areas of Expertise:

Microneedle Devices

Cancer Immunotherapy

Glucose-Responsive Insulin

Checkpoint Inhibitors

Artificial Beta Cells

Controlled-Release Dosage Forms

Therapeutic Agents

Nanoparticles

Adipose Tissue Browning

Protein Delivery

Dual-Sensitive Vesicles

Dermal Applicator

30 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12697474 - Core-shell microneedle devices and uses thereof (2026-08-04),

2. 12214078 - Artificial beta cells and methods of use thereof (2025-02-04),

3. 12161749 - Microneedle-array patches with glucose-responsive matrix for closed-loop insulin delivery (2024-12-10),

4. 12161720 - Cell assembly-mediated delivery of checkpoint inhibitors for cancer immunotherapy (2024-12-10),

5. 12053523 - Compositions comprising chemotherapeutic agents and checkpoint inhibitors and methods of use (2024-08-06),

6. 11896800 - Enhanced cancer immunotherapy by microneedle patch-assisted delivery (2024-02-13),

7. 11896673 - Glucose responsive insulin delivery compositions and methods (2024-02-13),

8. 11865178 - Dermal applicator for use in cancer photoimmunotherapy (2024-01-09),

9. 11850285 - Insulin-responsive glucagon delivery patch (2023-12-26),

10. 11826358 - Locally-induced adipose tissue browning by microneedle patch for obesity treatment (2023-11-28),

11. 11813352 - Charge-switchable polymeric depot for glucose-triggered insulin delivery with ultrafast response (2023-11-14),

12. 11786713 - Methods and compositions related to physiologically responsive microneedle delivery systems (2023-10-17),

13. 11760785 - Glucose transporter inhibitor-modified insulin for glucose-responsive insulin delivery (2023-09-19),

14. 11752098 - Core-shell microneedle patch for HOand pH cascade-triggered insulin delivery (2023-09-12),

15. 11730765 - Platelet compositions and methods for the delivery of therapeutic agents (2023-08-22),

Title: The Innovative Mind of Zhen Gu

Introduction: Zhen Gu, a talented inventor based in Los Angeles, CA, is known for his groundbreaking contributions to the field of biotechnology and drug delivery systems.

Latest Patents: Zhen Gu's latest patents include a novel drug delivery device for targeted cancer therapy and a smart insulin patch for diabetes management.

Career Highlights: With a Ph.D. in Biomedical Engineering, Zhen Gu has established himself as a leading figure in the intersection of medicine and technology. He has received numerous awards for his innovative research and has published extensively in top scientific journals.

Collaborations: Zhen Gu has collaborated with renowned pharmaceutical companies, leading research institutions, and medical professionals to bring his inventions to life. His collaborative spirit has led to the development of cutting-edge medical technologies.

Conclusion: Zhen Gu's passion for innovation and his dedication to improving healthcare through technology make him a true pioneer in the field of biotechnology. His work continues to inspire and drive progress in the medical industry.